CAR architecture has evolved through four generations. The first relied solely on CD3ζ and lacked potency. Second-generation receptors added either CD28 or 4-1BB costimulation, striking a balance ...

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...

Traditional therapeutics target the inactive conformation of proteins, allowing tumors to adapt and resume signaling.

Dr. Priya Hays discusses the mechanisms of treatment resistance in cancer, highlighting their significance for developing ...

Researchers tested experimental PCAI compounds against pancreatic cancer cells carrying KRAS mutations. One leading compound ...

Chemists at Université de Montréal have developed "signaling cascades" made with DNA molecules to report and quantify the concentration of various molecules in a drop of blood, all within five minutes ...